GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetron Holdings Ltd (NAS:GTH) » Definitions » YoY EPS Growth

Genetron Holdings (Genetron Holdings) YoY EPS Growth : -144.75% (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Genetron Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Genetron Holdings's YoY EPS Growth for the quarter that ended in Jun. 2022 was -144.75%.

Genetron Holdings's Earnings per Share (Diluted) for the three months ended in Jun. 2022 was $-1.14.


Genetron Holdings YoY EPS Growth Historical Data

The historical data trend for Genetron Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetron Holdings YoY EPS Growth Chart

Genetron Holdings Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
YoY EPS Growth
Get a 7-Day Free Trial -3.75 -42.67 -457.84 89.11 -47.23

Genetron Holdings Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -169.01 -124.52 -55.90 -144.75 100.00

Genetron Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Genetron Holdings's YoY EPS Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EPS Growth (A: Dec. 2022 )
=(Earnings per Share (Diluted) (A: Dec. 2022 )-Earnings per Share (Diluted) (A: Dec. 2021 ))/ | Earnings per Share (Diluted) (A: Dec. 2021 ) |
=(-3.744--2.543)/ | -2.543 |
=-47.23 %

Genetron Holdings's YoY EPS Growth for the quarter that ended in Jun. 2022 is calculated as:

YoY EPS Growth (Q: Jun. 2022 )
=(Earnings per Share (Diluted) (Q: Jun. 2022 )-Earnings per Share (Diluted) (Q: Jun. 2021 )) / | Earnings per Share (Diluted) (Q: Jun. 2021 )) |
=(-1.143--0.467)/ | -0.467 |
=-144.75 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetron Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Genetron Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetron Holdings (Genetron Holdings) Business Description

Traded in Other Exchanges
N/A
Address
No. 8 Life Science Parkway, 1-2nd Floor, Building 11, Zone 1, Changping District, Beijing, CHN, 102206
Genetron Holdings Ltd is an oncology company in China. It is specialized in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The company's operating segment includes Diagnosis and monitoring - provision for LDT services; Diagnosis and monitoring - sale of IVD products and Development services. It generates maximum revenue from the Diagnosis and monitoring - provision for LDT services segment.

Genetron Holdings (Genetron Holdings) Headlines